← Every company

Vertex Pharmaceuticals Inc SEC Filings

What Vertex Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

VRTX overview →
Filings on file
119
since Oct 14, 2016
Warning signs
3
latest Sep 17, 2019
Last results
Aug 3, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Sep 1, 2026
Executive or director change
8-K
Read ↗
Aug 4, 2026
Quarterly report
10-Q
Read ↗
Aug 3, 2026
Results announced
8-K
Read ↗
Jul 7, 2026
Material agreement
8-K
Read ↗
May 13, 2026
Executive or director changeShareholder vote
8-K
Read ↗
May 5, 2026
Quarterly report
10-Q
Read ↗
May 4, 2026
Results announced
8-K
Read ↗
Apr 29, 2026
Executive or director change
8-K
Read ↗
Feb 13, 2026
Annual report
10-K
Read ↗
Feb 12, 2026
Results announced
8-K
Read ↗
Nov 4, 2025
Quarterly report
10-Q
Read ↗
Nov 3, 2025
Results announced
8-K
Read ↗
Aug 5, 2025
Quarterly report
10-Q
Read ↗
Aug 4, 2025
Executive or director changeResults announced
8-K
Read ↗
May 14, 2025
Shareholder vote
8-K
Read ↗
May 6, 2025
Quarterly report
10-Q
Read ↗
May 5, 2025
Results announced
8-K
Read ↗
Feb 13, 2025
Annual report
10-K
Read ↗
Feb 10, 2025
Executive or director changeResults announced
8-K
Read ↗
Nov 5, 2024
Quarterly report
10-Q
Read ↗
Nov 4, 2024
Results announced
8-K
Read ↗
Aug 16, 2024
Material agreement
8-K
Read ↗
Aug 2, 2024
Quarterly report
10-Q
Read ↗
Aug 1, 2024
Results announced
8-K
Read ↗
May 15, 2024
Shareholder vote
8-K
Read ↗
May 7, 2024
Quarterly report
10-Q
Read ↗
May 6, 2024
Results announced
8-K
Read ↗
Apr 22, 2024
Tender offer
SC TO-T
Read ↗
Apr 11, 2024
Material agreement
8-K
Read ↗
Feb 15, 2024
Annual report
10-K
Read ↗
Feb 5, 2024
Results announced
8-K
Read ↗
Dec 5, 2023
Executive or director change
8-K
Read ↗
Nov 7, 2023
Quarterly report
10-Q
Read ↗
Nov 6, 2023
Results announced
8-K
Read ↗
Oct 5, 2023
Executive or director change
8-K
Read ↗
Aug 2, 2023
Quarterly report
10-Q
Read ↗
Aug 1, 2023
Results announced
8-K
Read ↗
May 18, 2023
Shareholder vote
8-K
Read ↗
May 2, 2023
Quarterly report
10-Q
Read ↗
May 1, 2023
Results announced
8-K
Read ↗
Feb 10, 2023
Annual report
10-K
Read ↗
Feb 7, 2023
Results announced
8-K
Read ↗
Oct 28, 2022
Quarterly report
10-Q
Read ↗
Oct 27, 2022
Results announced
8-K
Read ↗
Aug 5, 2022
Quarterly report
10-Q
Read ↗
Aug 4, 2022
Results announced
8-K
Read ↗
Jul 5, 2022
Material agreementNew debt
8-K
Read ↗
May 18, 2022
Shareholder vote
8-K
Read ↗
May 6, 2022
Quarterly report
10-Q
Read ↗
May 5, 2022
Results announced
8-K
Read ↗
Feb 9, 2022
Annual report
10-K
Read ↗
Jan 26, 2022
Results announced
8-K
Read ↗
Nov 3, 2021
Quarterly report
10-Q
Read ↗
Nov 2, 2021
Results announced
8-K
Read ↗
Jul 30, 2021
Quarterly report
10-Q
Read ↗
Jul 29, 2021
Results announced
8-K
Read ↗
May 19, 2021
Shareholder vote
8-K
Read ↗
Apr 30, 2021
Quarterly report
10-Q
Read ↗
Apr 29, 2021
Results announced
8-K
Read ↗
Apr 20, 2021
Material agreement
8-K
Read ↗
Feb 11, 2021
Annual report
10-K
Read ↗
Feb 1, 2021
Results announced
8-K
Read ↗
Oct 30, 2020
Quarterly report
10-Q
Read ↗
Oct 29, 2020
Results announced
8-K
Read ↗
Sep 21, 2020
Material agreementNew debt
8-K
Read ↗
Jul 31, 2020
Quarterly report
10-Q
Read ↗
Jul 30, 2020
Results announced
8-K
Read ↗
Jun 3, 2020
Shareholder vote
8-K
Read ↗
May 1, 2020
Quarterly report
10-Q
Read ↗
Apr 29, 2020
Results announced
8-K
Read ↗
Apr 1, 2020
Executive or director change
8-K
Read ↗
Feb 13, 2020
Annual report
10-K
Read ↗
Jan 30, 2020
Results announced
8-K
Read ↗
Oct 31, 2019
Quarterly report
10-Q
Read ↗
Oct 30, 2019
Results announced
8-K
Read ↗
Sep 17, 2019
Debt acceleratedMaterial agreementNew debt
8-K
Read ↗
Sep 3, 2019
Material agreement
8-K
Read ↗
Aug 1, 2019
Quarterly report
10-Q
Read ↗
Jul 31, 2019
Results announced
8-K
Read ↗
Jul 25, 2019
Executive or director change
8-K
Read ↗
Jun 7, 2019
Material agreement
8-K
Read ↗
Jun 5, 2019
Executive or director changeShareholder vote
8-K
Read ↗
May 1, 2019
Quarterly report
10-Q
Read ↗
Apr 30, 2019
Results announced
8-K
Read ↗
Apr 2, 2019
Executive or director change
8-K
Read ↗
Feb 22, 2019
Executive or director change
8-K
Read ↗
Feb 13, 2019
Annual report
10-K
Read ↗
Feb 5, 2019
Results announced
8-K
Read ↗
Jan 23, 2019
Executive or director change
8-K
Read ↗
Dec 17, 2018
Executive or director change
8-K
Read ↗
Oct 25, 2018
Quarterly report
10-Q
Read ↗
Oct 24, 2018
Results announced
8-K
Read ↗
Jul 26, 2018
Quarterly report
10-Q
Read ↗
Jul 25, 2018
Results announced
8-K
Read ↗
May 18, 2018
Material agreementShareholder vote
8-K
Read ↗
Apr 27, 2018
Quarterly report
10-Q
Read ↗
Apr 26, 2018
Results announced
8-K
Read ↗
Feb 15, 2018
Annual report
10-K
Read ↗
Jan 31, 2018
Results announced
8-K
Read ↗
Oct 30, 2017
Quarterly report
10-Q
Read ↗
Oct 27, 2017
Acquisition or sale completed
8-K/A
Read ↗
Oct 25, 2017
Material impairmentResults announcedAcquisition or sale completed
8-K
Read ↗
Sep 6, 2017
Executive or director change
8-K
Read ↗
Jul 28, 2017
Quarterly report
10-Q
Read ↗
Jul 26, 2017
Results announced
8-K
Read ↗
Jun 8, 2017
Material agreementShareholder vote
8-K
Read ↗
Apr 28, 2017
Quarterly report
10-Q
Read ↗
Apr 27, 2017
Results announced
8-K
Read ↗
Mar 6, 2017
Material agreement
8-K
Read ↗
Feb 23, 2017
Annual report
10-K
Read ↗
Jan 25, 2017
Results announced
8-K
Read ↗
Jan 11, 2017
Material agreement
8-K
Read ↗
Jan 9, 2017
Results announced
8-K/A
Read ↗
Jan 9, 2017
Results announced
8-K
Read ↗
Dec 2, 2016
Executive or director change
8-K
Read ↗
Oct 31, 2016
Quarterly report
10-Q
Read ↗
Oct 25, 2016
Results announced
8-K
Read ↗
Oct 17, 2016
Debt acceleratedMaterial agreementNew debt
8-K
Read ↗
Oct 14, 2016
Material agreement
8-K
Read ↗

Source: Vertex Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on VRTX

Related datasets